Suzhou Huajian Medical Laboratory Technology Co., Ltd. (referred to as Huajian Medical) is a first-level subsidiary of Jiangsu Microdiag and a marketing center of Weizhen. The marketing center is mainly responsible for the national hospital market sales of CST4, Septin9 and future molecular diagnostic products.
Existing Products:
New molecular marker for colorectal cancer blood test - Septin9 gene methylation detection kit;
The world's exclusive new tumor marker for gastrointestinal cancer - CST4 quantitative detection kit.
